Skip to main content
aap Implantate AG logo

aap Implantate AG — Investor Relations & Filings

Ticker · AAQ1 ISIN · DE000A3H2101 LEI · 39120001TRQTQ01LPP57 F Manufacturing
Filings indexed 854 across all filing types
Latest filing 2022-04-12 Audit Report / Informat…
Country DE Germany
Listing F AAQ1

About aap Implantate AG

https://www.aap.de/

aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.

Recent filings

Filing Released Lang Actions
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
Audit Report / Information Classification · 98% confidence The document text contains a detailed 'Inhaltsverzeichnis' (Table of Contents) which lists sections like 'Zusammengefasster Lagebericht' (Summarized Management Report), 'Geschäfts- und Rahmenbedingungen' (Business and Framework Conditions), 'Wirtschaftsbericht' (Economic Report), 'Risiko- und Chancenbericht' (Risk and Opportunity Report), and crucially, 'Jahresabschluss der aap Implantate AG' (Annual Financial Statements of aap Implantate AG) including the 'Gewinn- und Verlustrechnung' (Income Statement) and 'Bilanz' (Balance Sheet) for the period ending December 31, 2021. The structure, depth, and inclusion of the full annual financial statements and management report strongly indicate this is the company's official annual report, which corresponds to the 10-K filing type in the US context, or its equivalent comprehensive annual filing. FY 2021
2022-04-12 German
First surgeries performed as part of human clinical study for antibacterial silver coating technology; aap's technology effective against particularly critical antibiotic-resistant hospital germ MRSA
Regulatory Filings Classification · 99% confidence The document is a news release dated April 6, 2022, disseminated via DGAP, which is a service often used for regulatory announcements and corporate news in Germany. The content discusses clinical study progress and scientific findings related to the company's technology, rather than presenting a full financial report (like 10-K or IR) or a specific shareholder vote result. It is an update on operational and scientific progress. Since it is a general corporate news announcement distributed through a regulatory news service (DGAP) and doesn't fit the specific categories like ER (Earnings Release), CT (Call Transcript), or DIV (Dividend Notice), the most appropriate general category is Regulatory Filings (RNS), which serves as the fallback for miscellaneous corporate announcements not covered by more specific codes.
2022-04-06 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement titled 'Total Voting Rights Announcement' from aap Implantate AG, dated March 31, 2022. It explicitly mentions the publication of the total number of voting rights (5,959,531) and references a 'Type of capital measure' (Conditional capital increase). This type of mandatory disclosure regarding changes in the total number of shares/voting rights, often triggered by capital structure events, fits best under 'Share Issue/Capital Change' (SHA) or potentially a general 'Regulatory Filing' (RNS). Since the core content is the announcement of the new total voting rights following a capital measure, SHA is the most specific fit, as it relates directly to the capital structure change that necessitated the announcement. Given the short length and the nature of the announcement, it is not a comprehensive report.
2022-03-31 English
Turnaround in FY/2021: Significant sales growth (+30%) and substantially improved EBIDTA (+84%) - clear trend towards black zero
Earnings Release Classification · 100% confidence The document is explicitly titled with keywords like "Annual Results/Annual Report" in the DGAP header. It provides a comprehensive summary of the company's financial performance for the full fiscal year 2021 (FY/2021), including detailed figures for Sales, EBITDA, Cash flow, and Balance sheet, along with an outlook for FY/2022. The content strongly aligns with the definition of an Annual Report, which typically contains these elements. Although it is presented as a news release (DGAP-News), the substance is the annual financial summary, making '10-K' (Annual Report) the most appropriate classification for the underlying content type, as opposed to a brief announcement (RPA/RNS). The mention of an 'unqualified audit opinion' further supports this being the official annual disclosure. FY 2021
2022-03-31 English
Jahresfinanzbericht 2021
Annual Report Classification · 100% confidence The document is a comprehensive annual report for 'aap Implantate AG' for the fiscal year 2021. It includes a 'Vorwort des Vorstands' (CEO letter), a 'Zusammengefasster Lagebericht' (Management Report), and a detailed table of contents listing financial statements such as 'Konzernbilanz' (Consolidated Balance Sheet), 'Konzerngesamtergebnisrechnung' (Consolidated Statement of Comprehensive Income), and 'Konzernanhang' (Notes to the Consolidated Financial Statements). This structure is characteristic of a full Annual Report (10-K equivalent in the German context). FY 2021
2022-03-31 German
Report Publication Announcement 2022
Report Publication Announcement Classification · 100% confidence The document is a short announcement dated March 29, 2022, explicitly titled "Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG". It states that the 'Annual financial report' and 'Annual financial report of the group' will be disclosed on March 31, 2022, and provides a link to where they will be available. According to Rule #2 (The 'MENU VS MEAL' Rule), a short document announcing the publication of a report, rather than containing the report itself, should be classified as a Report Publication Announcement (RPA).
2022-03-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.